Downregulation of c-Met expression does not enhance the sensitivity of gastric cancer cell line MKN-45 to gefitinib

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 2269-2275

Spandidos Publications

Access to resources Recommend Favorite

Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC

By            

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1064-1068

Spandidos Publications

Access to resources Recommend Favorite

The Role of Epithelial–Mesenchymal Transition and IGF-1R Expression in Prediction of Gefitinib Activity as the Second-Line Treatment for Advanced Nonsmall-Cell Lung Cancer

By Chen Bei   Xiao Feng   Li Baofeng   Xie Bo   Zhou Juan   Zheng Jihua   Zhang Weimin  

Cancer Investigation, Vol. 31, Iss. 7, 2013-08 ,pp. : 454-460

Informa Healthcare

Access to resources Recommend Favorite

Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

By              

Experimental and Therapeutic Medicine, Vol. 10, Iss. 1, 2015-01 ,pp. : 386-388

Spandidos Publications

Access to resources Recommend Favorite

The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line

By                

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1944-1952

Spandidos Publications

Access to resources Recommend Favorite